Martin Møller

Chairman of the Board

Education: MA in humanities from the University of Copenhagen.

Background: Worked for more than 20 years at the international management consulting firm McKinsey & Company, specializing in healthcare, biotech, pharmaceuticals and life sciences, since 2007 as a Partner and since 2013 as a Senior Partner, until 2021. In that role, he has advised companies globally on strategy, growth and transformations, including drug development and innovation.

Other ongoing assignments: Chairman Re-Zip ApS, Board member in Immunovia AB and Rehaler A/S.

Independence: Independent in relation to both the Company and executive management.

Scandion Oncology shares and warrants
6.266 shares and 128.542 warrants.